MedTrace Logo

Identification of Polymorphisms Involved in the Metabolism of Propofol

NCT02271542 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-10-18

No results posted yet for this study

Summary

Identification of Polymorphisms Involved in the Metabolism of Propofol

Conditions

  • UGT1A1*28 Polymorphism

Interventions

DRUG

propofol

Propofol, 1-2 mg / kg after the installation is 100 to 200 mg / kg / min infusion for 30-60 minutes after application will be made and EDTA tubes with 2 ml blood sample will be taken. Determined from blood samples obtained by studying the polymorphism genotypes of patients will be exposed.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Halil AKBULUT, Resident · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271542 on ClinicalTrials.gov